5-[(E)-2-Bromovinyl]-2'-deoxyuridine(CAS: 69304-47-8)

5-[(E)-2-Bromovinyl]-2'-deoxyuridine (CAS: 69304-47-8) must comply with GHS (Globally Harmonized System) classification, REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) regulations, and FDA/EPA guidelines for hazardous substances. Specific requirements include proper labeling, documentation, and handling procedures to ensure worker and environmental safety.

Alternatives to 5-[(E)-2-Bromovinyl]-2'-deoxyuridine (CAS: 69304-47-8) in synthesis include other nucleoside analogs and brominated compounds. Common substitutes include 5-bromouracil and related derivatives. These alternatives may offer similar properties but are chosen based on specific reaction conditions and desired outcomes.

The market and research trend for 5-[(E)-2-Bromovinyl]-2'-deoxyuridine (CAS: 69304-47-8) is focused on its use as a potential antiviral and antitumor agent. Recent studies have explored its efficacy in combating viral infections and cancer. The trend indicates increasing interest in developing and optimizing its applications in pharmaceutical and therapeutic fields.

Waste containing 5-[(E)-2-Bromovinyl]-2'-deoxyuridine (CAS: 69304-47-8) should be collected in appropriate containers and stored in a secure, well-ventilated area. For disposal, use professional waste disposal services to ensure environmental safety. Follow local regulations and guidelines for hazardous waste management to minimize environmental impact and comply with legal requirements.